These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35246663)
1. ClpP inhibitors are produced by a widespread family of bacterial gene clusters. Culp EJ; Sychantha D; Hobson C; Pawlowski AC; Prehna G; Wright GD Nat Microbiol; 2022 Mar; 7(3):451-462. PubMed ID: 35246663 [TBL] [Abstract][Full Text] [Related]
2. The ADEP Biosynthetic Gene Cluster in Streptomyces hawaiiensis NRRL 15010 Reveals an Accessory Thomy D; Culp E; Adamek M; Cheng EY; Ziemert N; Wright GD; Sass P; Brötz-Oesterhelt H Appl Environ Microbiol; 2019 Oct; 85(20):. PubMed ID: 31399403 [TBL] [Abstract][Full Text] [Related]
3. Identification and Characterization of Approved Drugs and Drug-Like Compounds as Covalent Sassetti E; Durante Cruz C; Tammela P; Winterhalter M; Augustyns K; Gribbon P; Windshügel B Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159170 [TBL] [Abstract][Full Text] [Related]
4. ClpP Peptidase as a Plausible Target for the Discovery of Novel Antibiotics. Bhardwaj S; Roy KK Curr Drug Targets; 2024; 25(2):108-120. PubMed ID: 38151841 [TBL] [Abstract][Full Text] [Related]
5. The development of small-molecule modulators for ClpP protease activity. Ye F; Li J; Yang CG Mol Biosyst; 2016 Dec; 13(1):23-31. PubMed ID: 27831584 [TBL] [Abstract][Full Text] [Related]
6. ClpP Protease, a Promising Antimicrobial Target. Moreno-Cinos C; Goossens K; Salado IG; Van Der Veken P; De Winter H; Augustyns K Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067645 [TBL] [Abstract][Full Text] [Related]
7. Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization. Hackl MW; Lakemeyer M; Dahmen M; Glaser M; Pahl A; Lorenz-Baath K; Menzel T; Sievers S; Böttcher T; Antes I; Waldmann H; Sieber SA J Am Chem Soc; 2015 Jul; 137(26):8475-83. PubMed ID: 26083639 [TBL] [Abstract][Full Text] [Related]
8. Structure of Staphylococcus aureus ClpP Bound to the Covalent Active-Site Inhibitor Cystargolide A. Illigmann A; Vielberg MT; Lakemeyer M; Wolf F; Dema T; Stange P; Kuttenlochner W; Liebhart E; Kulik A; Staudt ND; Malik I; Grond S; Sieber SA; Kaysser L; Groll M; Brötz-Oesterhelt H Angew Chem Int Ed Engl; 2024 Jan; 63(3):e202314028. PubMed ID: 38029352 [TBL] [Abstract][Full Text] [Related]
9. α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease. Moreno-Cinos C; Sassetti E; Salado IG; Witt G; Benramdane S; Reinhardt L; Cruz CD; Joossens J; Van der Veken P; Brötz-Oesterhelt H; Tammela P; Winterhalter M; Gribbon P; Windshügel B; Augustyns K J Med Chem; 2019 Jan; 62(2):774-797. PubMed ID: 30571121 [TBL] [Abstract][Full Text] [Related]
10. Activators of cylindrical proteases as antimicrobials: identification and development of small molecule activators of ClpP protease. Leung E; Datti A; Cossette M; Goodreid J; McCaw SE; Mah M; Nakhamchik A; Ogata K; El Bakkouri M; Cheng YQ; Wodak SJ; Eger BT; Pai EF; Liu J; Gray-Owen S; Batey RA; Houry WA Chem Biol; 2011 Sep; 18(9):1167-78. PubMed ID: 21944755 [TBL] [Abstract][Full Text] [Related]
11. The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. Kirstein J; Hoffmann A; Lilie H; Schmidt R; Rübsamen-Waigmann H; Brötz-Oesterhelt H; Mogk A; Turgay K EMBO Mol Med; 2009 Apr; 1(1):37-49. PubMed ID: 20049702 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure at 1.9A of E. coli ClpP with a peptide covalently bound at the active site. Szyk A; Maurizi MR J Struct Biol; 2006 Oct; 156(1):165-74. PubMed ID: 16682229 [TBL] [Abstract][Full Text] [Related]
14. Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development. Jacques S; van der Sloot AM; C Huard C; Coulombe-Huntington J; Tsao S; Tollis S; Bertomeu T; Culp EJ; Pallant D; Cook MA; Bonneil E; Thibault P; Wright GD; Tyers M Genetics; 2020 Apr; 214(4):1103-1120. PubMed ID: 32094149 [TBL] [Abstract][Full Text] [Related]
16. Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism. Lee BG; Park EY; Lee KE; Jeon H; Sung KH; Paulsen H; Rübsamen-Schaeff H; Brötz-Oesterhelt H; Song HK Nat Struct Mol Biol; 2010 Apr; 17(4):471-8. PubMed ID: 20305655 [TBL] [Abstract][Full Text] [Related]
17. Functional Characterisation of ClpP Mutations Conferring Resistance to Acyldepsipeptide Antibiotics in Firmicutes. Malik IT; Pereira R; Vielberg MT; Mayer C; Straetener J; Thomy D; Famulla K; Castro H; Sass P; Groll M; Brötz-Oesterhelt H Chembiochem; 2020 Jul; 21(14):1997-2012. PubMed ID: 32181548 [TBL] [Abstract][Full Text] [Related]
18. Open and compressed conformations of Francisella tularensis ClpP. Díaz-Sáez L; Pankov G; Hunter WN Proteins; 2017 Jan; 85(1):188-194. PubMed ID: 27802578 [TBL] [Abstract][Full Text] [Related]
19. Ureadepsipeptides as ClpP Activators. Griffith EC; Zhao Y; Singh AP; Conlon BP; Tangallapally R; Shadrick WR; Liu J; Wallace MJ; Yang L; Elmore JM; Li Y; Zheng Z; Miller DJ; Cheramie MN; Lee RB; LaFleur MD; Lewis K; Lee RE ACS Infect Dis; 2019 Nov; 5(11):1915-1925. PubMed ID: 31588734 [TBL] [Abstract][Full Text] [Related]
20. The Role of ClpP Protease in Bacterial Pathogenesis and Human Diseases. Bhandari V; Wong KS; Zhou JL; Mabanglo MF; Batey RA; Houry WA ACS Chem Biol; 2018 Jun; 13(6):1413-1425. PubMed ID: 29775273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]